medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2019-19-165-168medsovet-5358Research ArticleПоддерживающая терапия в онкологииSupportive care in oncologyЛечение вариативного болевого синдрома при лучевой терапии костных метастазов рака молочной железыTreatment of variable pain syndrome in radiation therapy of bone metastases of breast cancerhttps://orcid.org/0000-0002-0727-5758СарманаеваР. Р.SarmanayevaR. R.

врач Центра паллиативной помощи онкологическим больным

25834, Россия, Москва, 2-й Боткинский пр-д, д. 3

physician at the Palliative Care Center for Oncology

3, 2nd Botkinsky Ave., Moscow, 25834, Russia

r.sarm@mail.ruhttps://orcid.org/0000-0002-6146-2706АбузароваГ. Р.AbuzarovaG. R.

д.м.н., руководитель Центра паллиативной помощи

25834, Россия, Москва, 2-й Боткинский пр-д, д. 3

главный научный сотрудник организационно-методического отдела по паллиативной помощи научно-исследовательского института организации здравоохранения и медицинского менеджмента департамента здравоохранения Москвы

115088, Россия, Москва, ул. Шарикоподшипниковская, д. 9

Dr. of Sci. (Med), Head of the Palliative Care Centre,

3, 2nd Botkinsky Ave., Moscow, 25834, Russia

niiozmm@zdrav.mos.ruhttps://orcid.org/0000-0002-5177-2612БычковаН. В.BychkovaN. M.

к.м.н. заведующая дневным стационаром отдела лучевой терапии

25834, Россия, Москва, 2-й Боткинский пр-д, д. 3

к.м.н. заведующая дневным стационаром отдела лучевой терапии,

3, 2nd Botkinsky Ave., Moscow, 25834, Russia

bychkovanm@mail.ruhttps://orcid.org/0000-0001-8204-9032АлексееваГ. С.AlexeevaG. S.

д.м.н., заместитель генерального директора по лечебной работе

25834, Россия, Москва, 2-й Боткинский пр-д, д. 3

Dr. of Sci. (Med), Deputy Director General for Clinical Work,

3, 2nd Botkinsky Ave., Moscow, 25834, Russia

Московский научно-исследовательский онкологический институт имени П.А. Герцена – филиал Национального медицинского исследовательского центра радиологииРоссияP. A. Hertsen Moscow Oncology Research Center – branch of FSBI NMRRC of the Ministry of Health of RussiaRussian Federation201908122019019165168Copyright © Сарманаева Р.Р., Абузарова Г.Р., Бычкова Н.В., Алексеева Г.С., 20192019Сарманаева Р.Р., Абузарова Г.Р., Бычкова Н.В., Алексеева Г.С.Sarmanayeva R.R., Abuzarova G.R., Bychkova N.M., Alexeeva G.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/5358онкологияметастазы в костилечение болилучевая терапияoncologybone metastasespain managementradiation therapyReferencesReale C., Turkiewicz A.M., Reale C.A. Analgic treatment of pain associated with bone metastases. Crit Rev Oncol Hematol. 2001;37(1):1-11. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11164714.Reale C., Turkiewicz A.M., Reale C.A. Analgic treatment of pain associated with bone metastases. Crit Rev Oncol Hematol. 2001;37(1):1-11. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11164714.Li B.T., Wong M.H., Pavlakis N., et al. Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice. J Clin Med. 2014;3(1):1–24. doi: 10.3390/jcm3010001.Li B.T., Wong M.H., Pavlakis N., et al. Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice. J Clin Med. 2014;3(1):1–24. doi: 10.3390/jcm3010001.Wong M., Pavlakis N. Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press). 2011;3:35-60. doi: 10.2147/BCTT.S6655.Wong M., Pavlakis N. Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press). 2011;3:35-60. doi: 10.2147/BCTT.S6655.Mantyh P.W., Mechanisms of Malignant Bone pain. In: Cancer Pain. From Molecules to Saffering. Paice J.A., Bell R.F., Kalso E.A., Soyannwo O.A. IASP Press. Seattle; 2010:45-63.Mantyh P.W., Mechanisms of Malignant Bone pain. In: Cancer Pain. From Molecules to Saffering. Paice J.A., Bell R.F., Kalso E.A., Soyannwo O.A. IASP Press. Seattle; 2010:45-63.Mantyh P.W., Clohisy D.R., Koltzenburg M., et al. Molecular mechanisms of cancer pain. Nature Reviews. Cancer. 2002;2(3):201-209. doi: 10.1038/nrc747.Mantyh P.W., Clohisy D.R., Koltzenburg M., et al. Molecular mechanisms of cancer pain. Nature Reviews. Cancer. 2002;2(3):201-209. doi: 10.1038/nrc747.Falk S., Dickenson A.H. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol. 2014;32(16):1647-1654. doi: 10.1200/JCO.2013.51.7219.Falk S., Dickenson A.H. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol. 2014;32(16):1647-1654. doi: 10.1200/JCO.2013.51.7219.Baron J.A. Epidemiology of non-steroidal antiinflammatory drugs and cancer. Prog Exp Tumor Res. 2003;37:1-24. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12795046.Baron J.A. Epidemiology of non-steroidal antiinflammatory drugs and cancer. Prog Exp Tumor Res. 2003;37:1-24. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12795046.Huang X.Z., Gao P., Sun J.X., et al. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis. Cancer Causes Control. 2015;26(4):589-600. doi: 10.1007/s10552-015-0539-y.Huang X.Z., Gao P., Sun J.X., et al. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis. Cancer Causes Control. 2015;26(4):589-600. doi: 10.1007/s10552-015-0539-y.Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology. 1993;79(2):270-281. doi: 10.1097/00000542-199308000-00012.Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology. 1993;79(2):270-281. doi: 10.1097/00000542-199308000-00012.Fletcher D., Benoist J.M., Gautron M., Guilbaud G. Isobolographic analysis of interactions between intravenous morphine, propacetamol, and diclofenac in carrageenin-injected rats. Anesthesiology. 1997;87(2):317-326. doi: 10.1097/00000542-199708000-00019.Fletcher D., Benoist J.M., Gautron M., Guilbaud G. Isobolographic analysis of interactions between intravenous morphine, propacetamol, and diclofenac in carrageenin-injected rats. Anesthesiology. 1997;87(2):317-326. doi: 10.1097/00000542-199708000-00019.Ahmad I., Ahmed M.M., Ahsraf M.F., et al. Pain Management in Metastatic Bone Disease: A Literature Review. Cureus. 2018;10(9):e3286. doi: 10.7759/cureus.3286.Ahmad I., Ahmed M.M., Ahsraf M.F., et al. Pain Management in Metastatic Bone Disease: A Literature Review. Cureus. 2018;10(9):e3286. doi: 10.7759/cureus.3286.WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents World Health Organization 2018, Switzerland; 2019:41-50. Available at: https://www.who.int/ncds/management/palliative-сare/cancer-pain-guidelines/en/WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents World Health Organization 2018, Switzerland; 2019:41-50. Available at: https://www.who.int/ncds/management/palliative-сare/cancer-pain-guidelines/en/Zaporowska-Stachowiak I., Łuczak J., Hoffmann K., Stachowiak K., Bryl W., Sopata M. Managing metastatic bone pain: New perspectives, different solutions. Biomed Pharmacother. 2017;93:1277-1284. doi: 10.1016/j.biopha.2017.07.023.Zaporowska-Stachowiak I., Łuczak J., Hoffmann K., Stachowiak K., Bryl W., Sopata M. Managing metastatic bone pain: New perspectives, different solutions. Biomed Pharmacother. 2017;93:1277-1284. doi: 10.1016/j.biopha.2017.07.023.

The authors declare that there are no conflicts of interest present.